Works matching IS 15747891 AND DT 2024 AND VI 18 AND IP 3
Results: 19
An arms‐race against resistance: leukemic stem cells and lineage plasticity.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 475, doi. 10.1002/1878-0261.13606
- By:
- Publication type:
- Article
Retraction: p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 778, doi. 10.1002/1878-0261.13615
- Publication type:
- Article
PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 691, doi. 10.1002/1878-0261.13610
- By:
- Publication type:
- Article
Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 662, doi. 10.1002/1878-0261.13593
- By:
- Publication type:
- Article
cAMP‐phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 707, doi. 10.1002/1878-0261.13572
- By:
- Publication type:
- Article
ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 562, doi. 10.1002/1878-0261.13589
- By:
- Publication type:
- Article
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 479, doi. 10.1002/1878-0261.13582
- By:
- Publication type:
- Article
Building flexible and robust analysis frameworks for molecular subtyping of cancers.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 606, doi. 10.1002/1878-0261.13580
- By:
- Publication type:
- Article
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 726, doi. 10.1002/1878-0261.13577
- By:
- Publication type:
- Article
Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 677, doi. 10.1002/1878-0261.13576
- By:
- Publication type:
- Article
Single extracellular vesicle surface protein‐based blood assay identifies potential biomarkers for detection and screening of five cancers.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 743, doi. 10.1002/1878-0261.13586
- By:
- Publication type:
- Article
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 528, doi. 10.1002/1878-0261.13569
- By:
- Publication type:
- Article
POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 620, doi. 10.1002/1878-0261.13568
- By:
- Publication type:
- Article
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 641, doi. 10.1002/1878-0261.13564
- By:
- Publication type:
- Article
PTEN‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 580, doi. 10.1002/1878-0261.13563
- By:
- Publication type:
- Article
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 762, doi. 10.1002/1878-0261.13554
- By:
- Publication type:
- Article
Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 547, doi. 10.1002/1878-0261.13545
- By:
- Publication type:
- Article
Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 517, doi. 10.1002/1878-0261.13496
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 473, doi. 10.1002/1878-0261.13457
- Publication type:
- Article